Navigation Links
Power behind primordial soup discovered
Date:4/4/2013

th colleagues at JPL-Caltech to understand how these early batteries and the 'chemical life' they became part of might have developed into biological life. As part of this work they will be using facilities in the University of Leeds' Faculty of Engineering, currently used to test new fuel cells, to build a 'geological fuel cell' using minerals and gases common on the early Earth. Researchers will apply different chemicals to its surface and monitor the reactions take place and the chemical products which develop.

The team also hope to travel to Disko Island in Greenland which is home to the Earth's only naturally-occurring source of schreibersite, the mineral found in the Sikhote-Alin meteorite. Here, they hope to repeat their experiments and show that the same chemicals develop in an entirely Earth-originated setting.


'/>"/>

Contact: Richard Mellor
r.d.mellor@leeds.ac.uk
44-011-334-34031
University of Leeds
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Using fluctuating wind power
2. Inspiring teens with research virus: Expert-mentored bioscience contest proves a powerful vector
3. A dual look at photosystem II using the worlds most powerful X-ray laser
4. Solar power: Is it time for the big push?
5. Powerful enzymes create ethanol from agricultural harvest waste
6. Black piranha, megapiranha have most powerful bites of fish living or extinct, finds GW researcher
7. For power and status, dominance and skill trump likability
8. Dust-plumes power intercontinental microbial migrations
9. Ancient red dye powers new green battery
10. Renewables and storage could power grid 99.9 percent of the time
11. University of Tennessee researchers find fungus has cancer-fighting power
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 16, 2014  Automation is ... this more evident than at international borders. Over ... document scanners have allowed veteran travelers to self ... Passport Control (APC) Kiosks at an increasing number ... globe. According to Maxine ...
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... their offering. One major trend ... multimodal biometric systems. Multimodal biometric systems utilize more ... and identification purposes. This helps to reduce the ...
(Date:12/10/2014)... 8, 2014 You,ve been here before: you desperately ... remember your password, site key or the answer to your ... grade teacher? Today, Hoyos Labs , ... that will finally put an end to the frustration that ... . 1U leverages a user,s smartphone to acquire his ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... 2013Universit Laval researchers have developed a highly effective method for ... low-emissions fuel for vehicles. The team led by Professor Frdric-Georges ... issue of the Journal of the American Chemical Society ... convert methanol into carbon dioxide in a single step using ...
... of genetically modified mice that Western University scientists call ... run far but they aren,t smart, is furthering the ... Marco Prado and his team at Robarts Research Institute ... of this neurotransmitter becomes available in the brain. ...
... 2013 Based on its recent analysis of the ... with the 2013 European Frost & Sullivan Award for ... originally used for medical point-of-care testing to create an ... test requires only a single-step DNA collection procedure from ...
Cached Biology News:Too green to be true? Researchers develop highly effective method for converting CO2 into methanol 2'Forrest Gump' mice show too much of a good thing, can be bad 2Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market 2Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market 3Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market 4
(Date:12/24/2014)... Md. , Dec. 24, 2014  United ... today that Medtronic, Inc. (NYSE: MDT ... the U.S. Food and Drug Administration (FDA) for ... implantable drug infusion system (including a newly developed ... (treprostinil) Injection delivered intravenously to patients with ...
(Date:12/24/2014)... GMO corn cases filed across the United ... the process of being consolidated in a Kansas federal ... Re: Syngenta AG MIR 162 Corn Litigation, MDL No. ... of Kansas. , Management of the Syngenta GMO corn ... District Judge John W. Lungstrum.* , As a Missouri ...
(Date:12/24/2014)... 2014 The report provides ... its definition, classification, application and industry overview. ... process, and product cost structure. Production is ... analysis also covers upstream raw materials, equipment, ... trend and proposals. In the end, the ...
(Date:12/24/2014)... , Dec. 23, 2014 Vermillion, ... focused on gynecologic disease, announced today that investors ... , Birchview Fund LLC and several Vermillion directors ... unregistered shares of Vermillion,s common stock and warrants ... in a private placement.  Under ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5
... DUBLIN, October 28 , ... EU to Treat,hyperphosphataemia >1.78mmol/L in Chronic Kidney Disease Patients ... (LSE: SHP, NASDAQ: SHPGY ), the global specialty,biopharmaceutical ... Mutual Recognition Procedure for an extension to the current,indication ...
... ... An incident of terrorism, accident, or improper disposal of radioactive ... catastrophe would impact the population with increased cancer and associated illnesses ... distribution network. In response to this threat, Technical Associates created the ...
... Oct. 27 Regeneron Pharmaceuticals, Inc. (Nasdaq: ... authorization in the European Union for rilonacept, an ... Syndromes (CAPS) with severe symptoms, including Familial Cold ... adults and children aged 12 years and older. ...
Cached Biology Technology:Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease 2Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease 3Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease 4Safety in Drinking Water? Monitoring for Radioactive Contaminants Only Required Every Three, Six, or Nine Years per Federal Law 2Safety in Drinking Water? Monitoring for Radioactive Contaminants Only Required Every Three, Six, or Nine Years per Federal Law 3Safety in Drinking Water? Monitoring for Radioactive Contaminants Only Required Every Three, Six, or Nine Years per Federal Law 4Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) 2Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) 3Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) 4Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) 5Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) 6